De Novo Design and Molecular Dynamics Evaluation of AZ67-Derived Allosteric PFKFB3 Modulators for Anticancer Metabolic Drug Discovery. J. Can. Res. Updates [Internet]. 2026 Aug. 27 [cited 2026 Sep. 4];15(3):249-61. Available from: https://www.neoplasiaresearch.com/index.php/jcru/article/view/977